|
2010-12-07 |
Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults |
BIOCEN |
Registered |
|
2010-12-07 |
Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults |
BIOCEN |
Registered |
|
2010-12-07 |
Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults. |
BIOCEN |
Registered |
|
2010-12-08 |
Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults |
BIOCEN |
Registered |
|
2010-12-08 |
Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults. |
BIOCEN |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics. |
BIOCEN |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics |
BIOCEN |
Registered |
|
2010-12-09 |
Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults. |
BIOCEN |
Registered |
|
2010-12-09 |
Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics |
BIOCEN |
Registered |
|
2010-12-17 |
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I. |
CIM |
Registered |
|
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II |
CIM |
Registered |
|
2010-12-17 |
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II |
CIM |
Registered |
|
2010-12-17 |
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. |
CIM |
Registered |
|
2010-12-17 |
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors. |
CIM |
Registered |
|
2010-12-20 |
CIGB500 in healthy volunteers |
CIGB |
Registered |
|
2010-12-20 |
THERESA-2 Study |
CIGB |
Registered |
|
2010-12-20 |
Dynamic-I |
CIGB |
Registered |
|
2010-12-20 |
Dermosep-I |
CIGB |
Registered |
|
2010-12-20 |
EPANEM-III |
CIGB |
Registered |
|
2010-12-20 |
AntiCEA M3-I |
CIGB |
Registered |
